February 23, 2011
Posted by admin
ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction
Please find, below, a major IP-related announcement from the company.
ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction
IP Coverage for Proprietary Single-Blastomere Technology Could Facilitate Licensing Deals and Partnerships
MARLBOROUGH, Mass. – Feb. 23, 2011. Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced [...]